At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- [14C]GRT6019 (drug)
- How long the study runs
- Study runs about 3 months (dates as stated)
- About the drug or intervention
- [14C]GRT6019 — drug: Single administration in a single dosing period.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 30 Years to 65 Years
- Who
- Male
- Number of participants
- 10
- Started
- 2026-03-25
- Last checked
- 2026-08
Plain English Summary
What is this study?
- • Testing a new treatment for healthy male volunteers
- • Phase1 - 10 participants
- • The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019
Who can take part?
- • Ages 30 Years to 65 Years
- • Diagnosed with healthy male volunteers
- • Male only
Where?
- • Nottingham - Quotient Sciences
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019
More detail
This is an open-label, non-randomized, single-dose study in healthy male participants. It is planned to enroll a total of ten participants to ensure data in a minimum of six participants. The estimated time for duration of study will be up to 11 weeks.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 30 Years - 65 Years
- Who can join: Male only
What the study is looking for
- ✓Healthy volunteers
- ✓Aged 30 to 65 years inclusive at the time of signing agreement to take part
Who cannot take part
- ✗Serious adverse reaction or serious hypersensitivity to any drug or formulation excipients
- ✗Presence or history of clinically significant allergy requiring treatment, as judged by the investigator. Hay fever...
- ✗Presence or history of diseases or conditions known to interfere with the absorption, distribution, metabolism or...
- ✗History of GI surgery (with the exception of appendectomy or hernia repair unless it was performed within the...
See the full criteria
Where Is This Study? (1 UK site)
Quotient Sciences
Nottingham NG11 6JS, United Kingdom
